Aroa Biosurgery Investor Day 2021

Aroa Biosurgery is a high-growth soft tissue regeneration company with 5 patented products approved in 49 countries and over 4 million procedures performed. As of FY21, the company reported NZ$23.1m in product sales with 68% gross margin, operating in a >US$2.5b addressable market for hernia repair and reconstructive devices.